Structural formula: Ioversol

OPTIRAY 300 (300 mg l/ml), solution for injection in a vial bottle, 500 ml

Telegram WhatsApp

Link to share

Active ingredients: Iodine, Ioversol

Commercialized according to BDPMDispensing in France: Prescription only

Solution for injectionbottle, 500 mlintraartérielle;intraveineuse

No current ANSM shortage notice is included

Package details

Original BDPM fields are shown in French.

Official name: OPTIRAY 300 (300 mg l/mL), solution injectable en flacon
Pharmaceutical form: solution injectable
Route of administration: intraartérielle;intraveineuse
Presentation description: 1 flacon(s) en verre de 500 ml
Marketing authorisation holder: GUERBET
Reimbursement according to BDPM: —
Approval for use in healthcare institutions: oui
Commercialization declaration date: 11 Mar 2024
Prescription and dispensing conditions: Prescription only
List I: prescription-only medicine
Original BDPM wording: liste I · médicament soumis à prescription médicale
Enhanced ANSM monitoring: No

BDPM identifiers

CIS67722465CIP73028206CIP133400930282069

Composition in BDPM

Composition in BDPM
Component	Amount per unit	Source type
IODEsolution	30,0 g · 100 ml	FT
IOVERSOLsolution	63,6 g · 100 ml	SA

Information is based on BDPM data and is for reference only. Consult a doctor before use.

Other packages of this medicine

The same medicine in another pack size, according to BDPM.

Similar medicines

Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.

The current BDPM data does not list similar medicines for this product.